← Back to patent-cliff list
CAS 4637-24-5
(Dimethylamino)formaldehyde dimethyl acetal1,1-dimethoxy-N,N-dimethylmethanamineN,N-Dimethylformamide dimethyl acetal
Codes: (VII)461018-3-a, IGUR-018, Bromfenac Sodium-031
Application context (from source-drug indications)
Waldenström macroglobulinaemiaIbrutinibChronic lymphocytic leukaemiaIbrutinibMantle cell lymphomaIbrutinibGraft-versus-host diseaseIbrutinibRheumatoid arthritisIguratimodGraft-versus-host diseaseIguratimodSjögren's syndromeIguratimodInflammatory diseaseBromfenac SodiumPostoperative painBromfenac Sodium眼睛发炎Bromfenac Sodium眼睛疼痛Bromfenac SodiumDry eye syndromeBromfenac Sodium黄斑水肿Bromfenac Sodium
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Ibrutinib | Tier A — Act now | 2027 |
| Iguratimod | Tier C — Watch / trade | - |
| Bromfenac Sodium | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
4-Phenoxybenzoyl chloride→1,1-Dicyanomethane→(4-Phenoxybenzoyl)malononitrile→1,1-Dicyano-2-methoxy-2-(4-phenoxyphenyl)ethene→1-[(3R)-3-Hydrazinopiperidin-1-yl]prop-2-en-1-one→1-[(3R)-1-Acryloylpiperidin-3-yl]-5-amino-3-(4-phenoxyphenyl)-1H-pyrazole-4-carbonitrile→(Dimethylamino)formaldehyde dimethyl acetal
1-chloro-4-methoxy-2-nitrobenzene→phenol→4-methoxy-2-nitro-1-phenoxybenzene→5-methoxy-2-phenoxyaniline→N-(5-methoxy-2-phenoxyphenyl)methanesulfonamide→2-aminoacetonitrile hydrochloride→N-(4-glycyl-5-methoxy-2-phenoxyphenyl)methanesulfonamide→N-(2-(2-methoxy-4-(methylsulfonamido)-5-phenoxyphenyl)-2-oxoethyl)formamide→N-(2-(2-hydroxy-4-(methylsulfonamido)-5-phenoxyphenyl)-2-oxoethyl)formamide→1,1-dimethoxy-N,N-dimethylmethanamine
1-Ethyl-2-nitrobenzene→2-Ethylaniline→4-Bromobenzoyl chloride→(2-Amino-3-ethylphenyl)(4-bromophenyl)methanone→N,N-Dimethylformamide dimethyl acetal→[2-Amino-3-[3-(dimethylamino)prop-2-en-1-yl]phenyl](4-bromophenyl)methanone
Intermediates available on this site
Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.
| Supplier | Product | Price band | MOQ | Lead time | Qualifications | Action |
|---|---|---|---|---|---|---|
| Unibest Taizhou GMP-like Site | N-(4-glycyl-5-methoxy-2-phenoxyphenyl)methanesulfonamide
hydrochloride Pharmaceutical Intermediates | On request | On request | On request | — | |
| Qualified Partner — East China API Works | N-(5-Methoxy-2-phenoxyphenyl)methanesulfonamide Pharmaceutical Intermediates | On request | On request | On request | — | |
| Unibest Nantong cGMP Site | N-[4-[(Formylamino)acetyl] -5-hydroxy-2- phenoxyphenyl]methanesulfonamide Pharmaceutical Intermediates | On request | On request | On request | — |
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.